These two user fee programs enhance FDA’s ability to maintain a predictable and timely animal drug review process, foster innovation in drug development, and expedite access to new therapies for food-producing and companion animals.
via What's New: Animal & Veterinary http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm357130.htm
via What's New: Animal & Veterinary http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm357130.htm
No comments:
Post a Comment